SILIQ

Troubled pharmaceutical company Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced on Friday pricing for its SILIQ (brodalumab) injection. What Is SILIQ? The U.S. Food and Drug Administration approved the Biologics License Application for SILIQ, which is a monoclonal antibody that targets the...